Leal Health has announced that it presented a poster highlighting disparities in clinical trial participation among diverse ethnic communities at this year's American Association for Cancer Research (AACR) Conference on The Science of Cancer Health Disparities in Racial / Ethnic Minorities and the Medically Underserved.
The poster, titled, "Unveiling disparities in clinical trial participation: Exploring socioeconomic barriers and access to insurance among diverse ethnic groups," was presented by Ritta Jubran, medical director at Leal Health, and highlighted data from a multi-ethnic cohort of 4,525 new patient sign-ups in 2023. The study focused on the impact of several socioeconomic factors, such as insurance coverage and patients' willingness to travel to clinical trial locations, to identify obstacles within underserved communities that contribute to patients' underrepresentation in trials.
Key findings from the study include:
"Our findings from this study reinforce the urgent need to tackle socioeconomic challenges that prevent greater accessibility and inclusivity in clinical trials, especially for historically underrepresented patient communities," said Tzvia Bader, CEO and co-founder, Leal Health in a press release. "Achieving true, real-world representation in clinical trials is a crucial step toward ensuring equity in healthcare. In fact, last year, FDA released guidance for the healthcare industry to enroll more participants from underrepresented racial and ethnic populations into clinical trials. The only way to deliver effective cancer treatments for all patients, regardless of their socioeconomic background or ethnicity, is to remove the barriers that contribute to underrepresentation once and for all."
Leal Health Presents Poster Highlighting Disparities in Clinical Trial Participation Among Diverse Ethnic Groups. (2023, October 10). Cision PR Newswire.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.